Launch Therapeutics
Will Shambley is an accomplished finance professional with extensive experience in operations finance within the clinical research industry. Currently serving as the Executive Director, Head of Operations Finance at Launch Therapeutics since February 2023, Will has held various senior roles, including Senior Director of Financial Operations at Worldwide Clinical Trials from November 2021 to February 2023. Prior experience includes a progressive series of finance roles at PPD from June 2015 to November 2021, culminating as Director of Finance, and additional positions at INC Research and PPD earlier in Will’s career. Will's finance expertise is supported by a Bachelor of Science degree in Business Administration with a focus on Management and Finance from the University of North Carolina Wilmington, earned between 2004 and 2009.
This person is not in any teams
This person is not in any offices
Launch Therapeutics
Launch Therapeutics (Launch Tx) is a clinical development company with a mission to disrupt the late-stage development paradigm, accelerate timelines to regulatory success, and bring new medicines to patients, faster. To deliver this, Launch Tx offers pharmaceutical and biotech partners a variety of innovative models that combine access to capital with deep drug development, medical, clinical operations, regulatory, and commercialization expertise. These models include significant risk financing, clinical co-development, and full in-licensing, all of which offer partners an aligned and efficient approach to realizing the potential of late-stage clinical programs across any therapeutic area. Founded in 2022, Launch Tx is backed by the respected and experienced professionals at Carlyle and its life sciences franchise, Abingworth. By combining the global network of Carlyle and Abingworth with the seasoned team of professionals at Launch Tx, both pharmaceutical and biotech companies have an ideal partner to advance their late-stage clinical programs.